Genovis AB - Strategy, SWOT and Corporate Finance Report

Genovis AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Genovis AB (Genovis) develops, produces and markets enzyme products, which facilitate the development and quality control of biological drugs. The company’s products are used for antibody molecules analysis to identify and characterize proteins, antibody based biotherapeutics; monoclonal antibodies, antibody drug conjugates and biosimilars. Its SmartEnzymes product portfolio encompasses FabRICATOR (IdeS), GingisKHAN (KGP), FabULOUS (SpeB), GlycINATOR (EndoS49), FabRICATOR Z (IdeZ), GingisREX (Rgp) and IgGZERO (EndoS). Genovis also offers antibody fragmentation services for different species and subclasses of Immunoglobulin G antibodies. The company offers its products to medical device, pharmaceutical and biotechnology sectors as well as contract manufacturing companies. It has presence in Massachusetts, the US; Europe and other countries. Genovis is headquartered in Lund, Sweden.

Scope

  • Detailed information on Genovis AB required for business and competitor intelligence needs
  • A study of the major internal and external factors affecting Genovis AB in the form of a SWOT analysis
  • An in-depth view of the business model of Genovis AB including a breakdown and examination of key business segments
  • News about Genovis AB, such as business expansion, restructuring, and contract wins
  • Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

  • Gain understanding of Genovis AB and the factors that influence its strategies.
  • Track strategic initiatives of the company and latest corporate news and actions.
  • Assess Genovis AB as a prospective partner, vendor or supplier.
  • Support sales activities by understanding your customers' businesses better.
  • Stay up to date on Genovis ABs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Thermo Fisher Scientific Inc

ProZyme Inc

New England Biolabs Inc

GE Healthcare AB

Bio-Rad Laboratories Inc

Thermo Fisher Scientific Inc

ProZyme Inc

New England Biolabs Inc

GE Healthcare AB

Bio-Rad Laboratories Inc

Table of Contents

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1 - About the Company 6

Genovis AB - ...

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1 - About the Company 6

Genovis AB - Key Facts 6

Genovis AB - Key Employees 7

Genovis AB - Key Employee Biographies 8

Genovis AB - Key Operational Employees 9

Genovis AB - Major Products and Services 10

Genovis AB - History 11

Genovis AB - Company Statement 14

Genovis AB - Locations And Subsidiaries 15

Head Office 15

Other Locations & Subsidiaries 15

Section 2 – Company Analysis 16

Company Overview 16

Genovis AB - Business Description 17

Genovis AB - Corporate Strategy 18

Genovis AB - SWOT Analysis 19

SWOT Analysis - Overview 19

Genovis AB - Strengths 19

Genovis AB - Weaknesses 20

Genovis AB - Opportunities 21

Genovis AB - Threats 22

Genovis AB - Key Competitors 23

Section 3 – Company Financial Ratios 24

Financial Ratios - Capital Market Ratios 24

Financial Ratios - Annual Ratios 25

Performance Chart 27

Financial Performance 27

Financial Ratios - Interim Ratios 28

Financial Ratios - Ratio Charts 29

Section 4 – Company’s Lifesciences Financial Deals and Alliances 30

Genovis AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 30

Genovis AB, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 31

Genovis AB, Recent Deals Summary 32

Section 5 – Company’s Recent Developments 33

May 15, 2018: Genovis: Interim Report January – March 2018 33

Apr 26, 2018: Genovis launches GlycOCATCH for purification of O-glycosylated proteins 35

Apr 23, 2018: Proposal to expand the Genovis Board of Directors at 2018 Annual General Meeting 36

Apr 06, 2018: Genovis signs distribution agreement for South Korean market 37

Dec 08, 2017: Genovis Signs Distribution Agreement in India 38

Nov 27, 2017: Genovis Announces Interim Report January – September 2017 39

May 30, 2017: Genovis expands its product portfolio and launches three products for glycan analysis 40

May 02, 2017: Genovis expands its product portfolio and launches FabALACTICA 41

Feb 27, 2017: Genovis Announces Year-End Report January-December 2016 42

Section 6 – Appendix 48

Methodology 48

Ratio Definitions 48

About GlobalData 52

Contact Us 52

Disclaimer 52

List of Tables

List of Tables

Genovis AB, Key Facts 6

Genovis AB, Key Employees 7

Genovis AB, Key Employee Biographies 8

Genovis AB, Key Operational Employees 9 ...

List of Tables

Genovis AB, Key Facts 6

Genovis AB, Key Employees 7

Genovis AB, Key Employee Biographies 8

Genovis AB, Key Operational Employees 9

Genovis AB, Major Products and Services 10

Genovis AB, History 11

Genovis AB, Subsidiaries 15

Genovis AB, Key Competitors 23

Genovis AB, Ratios based on current share price 24

Genovis AB, Annual Ratios 25

Genovis AB, Annual Ratios (Cont...1) 26

Genovis AB, Interim Ratios 28

Genovis AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 30

Genovis AB, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 31

Genovis AB, Recent Deals Summary 32

Currency Codes 48

Capital Market Ratios 48

Equity Ratios 49

Profitability Ratios 49

Cost Ratios 50

Liquidity Ratios 50

Leverage Ratios 51

Efficiency Ratios 51

List of Figures

List of Figures

Genovis AB, Performance Chart (2013 - 2017) 27

Genovis AB, Ratio Charts 29

Genovis AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 ...

List of Figures

Genovis AB, Performance Chart (2013 - 2017) 27

Genovis AB, Ratio Charts 29

Genovis AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 30

Genovis AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 31

    Pricing

Discounts available for multiple report purchases.

reportstore@marketline.com
+44 (0) 161 359 5817

Saved reports